Developmental outcome of drug-exposed children through 30 months: a comparison of Bayley and Bayley-II

Psychol Assess. 2003 Sep;15(3):435-8. doi: 10.1037/1040-3590.15.3.435.

Abstract

This study examined the effects of the Bayley Scales of Infant Development (BSID) version on developmental outcomes among drug-exposed children, some of whom received an intervention. Developmental outcome was evaluated with the BSID at 12 and 18 months and with the BSID-II at 24 and 30 months. In the repeated measures analyses, children scored higher on the BSID Mental Developmental Index (MDI; p < .01) and Psychomotor Developmental Index (PDI; p < .01) than on the BSID-II MDI and PDI. Version x Time (p < .01) and Version x Group (p < .01) interactions were also found for the MDI but not the PDI. PDI scores decreased on both the BSID and the BSID-II (p < .01). Over the first 2 years postpartum, mean MDI and PDI scores decreased among these high-risk, drug-exposed children.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Child Development / drug effects*
  • Developmental Disabilities / diagnosis*
  • Drug-Related Side Effects and Adverse Reactions
  • Female
  • Humans
  • Infant
  • Male
  • Neuropsychological Tests* / standards
  • Neuropsychological Tests* / statistics & numerical data
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Time Factors